Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
European Journal of Preventive Cardiology
|
February 14, 2025
Socioeconomic disparities and risk of recurrent cardiovascular events and cardiovascular disease-free life expectancy in patients with established cardiovascular disease
Stella Bijkerk, Frank L J Visseren, Manon G van der Meer, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
June 1, 2026
Comparison of different long-term cardiovascular disease risk prediction horizons to guide preventive drug treatment in apparently healthy individuals
Stella Bijkerk, Janet M Kist, Lisa Pennells, et al.
JACC. Advances
|
November 14, 2025
Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients
Mari Nordbø Gynnild, Victoria Vinje-Jakobsen, Joris Holtrop, et al.
Heart (British Cardiac Society)
|
June 1, 2025
Identifying clinical phenotype clusters in patients with coronary artery disease
Joris Holtrop, Carl-Emil Lim, Alicia Uijl, et al.
European Journal of Preventive Cardiology
|
April 8, 2024
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model
Marga A G Helmink, Sanne A E Peters, Jan Westerink, et al.
European Journal of Preventive Cardiology
|
October 8, 2022
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)
Helena Bleken Østergaard, Steven H J Hageman, Stephanie H Read, et al.
European Journal of Preventive Cardiology
|
February 9, 2023
Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease
Tinka J van Trier, Marjolein Snaterse, Steven H J Hageman, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 10, 2025
Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention
Steven H J Hageman, Stephen Kaptoge, Mari N Gynnild, et al.
Diabetes, Obesity & Metabolism
|
March 8, 2024
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model
Marga A G Helmink, Steven H J Hageman, Björn Eliasson, et al.
International Journal of Cardiology
|
September 7, 2024
Adding ethnicity to cardiovascular risk prediction: External validation and model updating of SCORE2 using data from the HELIUS population cohort
Joshua A N van Apeldoorn, Steven H J Hageman, Ralf E Harskamp, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
European Journal of Preventive Cardiology
|
February 14, 2025
Socioeconomic disparities and risk of recurrent cardiovascular events and cardiovascular disease-free life expectancy in patients with established cardiovascular disease
Stella Bijkerk, Frank L J Visseren, Manon G van der Meer, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
June 1, 2026
Comparison of different long-term cardiovascular disease risk prediction horizons to guide preventive drug treatment in apparently healthy individuals
Stella Bijkerk, Janet M Kist, Lisa Pennells, et al.
JACC. Advances
|
November 14, 2025
Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients
Mari Nordbø Gynnild, Victoria Vinje-Jakobsen, Joris Holtrop, et al.
Heart (British Cardiac Society)
|
June 1, 2025
Identifying clinical phenotype clusters in patients with coronary artery disease
Joris Holtrop, Carl-Emil Lim, Alicia Uijl, et al.
European Journal of Preventive Cardiology
|
April 8, 2024
Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model
Marga A G Helmink, Sanne A E Peters, Jan Westerink, et al.
European Journal of Preventive Cardiology
|
October 8, 2022
Estimating individual lifetime risk of incident cardiovascular events in adults with Type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2)
Helena Bleken Østergaard, Steven H J Hageman, Stephanie H Read, et al.
European Journal of Preventive Cardiology
|
February 9, 2023
Unexploited potential of risk factor treatment in patients with atherosclerotic cardiovascular disease
Tinka J van Trier, Marjolein Snaterse, Steven H J Hageman, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 10, 2025
Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention
Steven H J Hageman, Stephen Kaptoge, Mari N Gynnild, et al.
Diabetes, Obesity & Metabolism
|
March 8, 2024
Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model
Marga A G Helmink, Steven H J Hageman, Björn Eliasson, et al.
International Journal of Cardiology
|
September 7, 2024
Adding ethnicity to cardiovascular risk prediction: External validation and model updating of SCORE2 using data from the HELIUS population cohort
Joshua A N van Apeldoorn, Steven H J Hageman, Ralf E Harskamp, et al.
Page
of 4